Amedeo Smart

Free Medical Literature Service



Bacterial Infections and Mycoses

  Free Subscription

Articles published in
    December 2018
  1. SAVIOLI L, Daumerie D
    WHO leadership is essential for the elimination of NTDs.
    Lancet. 2018;390:2765.
    >> Share

  2. YAQUB F
    2017: a year in review.
    Lancet. 2018;390:2753-2754.
    >> Share

    Our responsibility to protect the Rohingya.
    Lancet. 2018;390:2740.
    >> Share

    May 2018
    Managing MDR tuberculosis in Nepal.
    Lancet. 2018;391:1760-1761.
    >> Share

    March 2018
    Commitments to an end to tuberculosis renewed in India.
    Lancet. 2018;391:1138.
    >> Share

  6. GOOSBY E, Jamison D, Swaminathan S, Reid M, et al
    The Lancet Commission on tuberculosis: building a tuberculosis-free world.
    Lancet. 2018;391:1132-1133.
    >> Share

  7. WINGFIELD T, Tovar MA, Datta S, Saunders MJ, et al
    Addressing social determinants to end tuberculosis.
    Lancet. 2018;391:1129-1132.
    >> Share

    Leo Martinez: striving to end childhood tuberculosis.
    Lancet. 2018 Mar 21. pii: S0140-6736(18)30680.
    >> Share

    February 2018
  9. BURKI T
    End of a cholera epidemic in South Sudan declared.
    Lancet. 2018;391:647.
    >> Share

  10. MUHSEN K, Green MS, Soskolne V, Neumark Y, et al
    Inequalities in non-communicable diseases in Israel - Authors' reply.
    Lancet. 2018;391:537.
    >> Share

  11. WATTS N, Amann M, Ayeb-Karlsson S, Belesova K, et al
    The Lancet Countdown on health and climate change: from 25 years of inaction to a global transformation for public health.
    Lancet. 2018;391:581-630.
    >> Share

    Superbugs and us.
    Lancet. 2018;391:420.
    >> Share

    January 2018
    Mega-crisis in DR Congo.
    Lancet. 2018;391:297-298.
    >> Share

    A new vaccine for typhoid control.
    Lancet. 2018;391:96.
    >> Share

    Tuberculosis: criteria for global leadership?
    Lancet. 2018;391:2.
    >> Share

    December 2017
  16. HOLLAND TL, Fowler VG Jr
    Rifampicin for Staphylococcus aureus bacteraemia: give it ARREST.
    Lancet. 2017 Dec 14. pii: S0140-6736(17)33294.
    >> Share

  17. THWAITES GE, Scarborough M, Szubert A, Nsutebu E, et al
    Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.
    Lancet. 2017 Dec 14. pii: S0140-6736(17)32456.
    >> Share

    September 2017
    Tuberculosis and HIV/AIDS: the alien and the predator.
    Lancet. 2017;390:1618-1619.
    >> Share

  19. COX H, Reuter A, Furin J, Seddon J, et al
    Prevention of hearing loss in patients with multidrug-resistant tuberculosis.
    Lancet. 2017;390:934.
    >> Share

    July 2017
  20. YACOUB M, Mayosi B, ElGuindy A, Carpentier A, et al
    Eliminating acute rheumatic fever and rheumatic heart disease.
    Lancet. 2017;390:212-213.
    >> Share

    June 2017
    Tuberculosis in India: health policy alone is not enough.
    Lancet. 2017;389:2471.
    >> Share

  22. PAI M, Jha P
    Tuberculosis in India: health policy alone is not enough - Authors' reply.
    Lancet. 2017;389:2471-2472.
    >> Share

    Cholera outbreak in Haiti-from 2010 to today.
    Lancet. 2017;389:2274-2275.
    >> Share

    Cyclone Mora devastates south Asia.
    Lancet. 2017;389:2273.
    >> Share

  25. ALONSO P, Engels D, Reeder J
    Renewed push to strengthen vector control globally.
    Lancet. 2017;389:2270-2271.
    >> Share

    April 2017
  26. MCGILL F, Solomon T
    Acute bacterial meningitis in adults - Authors' reply.
    Lancet. 2017;389:1610.
    >> Share

  27. PHAN AD, Benchetrit L, Jacobs FM
    Acute bacterial meningitis in adults.
    Lancet. 2017;389:1609-1610.
    >> Share

    March 2017
    New plan to end tuberculosis in south and southeast Asia.
    Lancet. 2017;389:1183.
    >> Share

  29. ADAM BU, Cosford P, Anderson SR, Abubakar I, et al
    Sustaining tuberculosis decline in the UK.
    Lancet. 2017;389:1176-1177.
    >> Share

  30. PAI M, Correa N, Mistry N, Jha P, et al
    Reducing global tuberculosis deaths-time for India to step up.
    Lancet. 2017;389:1174-1176.
    >> Share

    February 2017
    India plans to expand access to new tuberculosis drug.
    Lancet. 2017;389:685.
    >> Share

    Myanmar grapples with its high tuberculosis burden.
    Lancet. 2017;389:491-492.
    >> Share

    January 2017
  33. CLINTON C, Sridhar D
    Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance.
    Lancet. 2017 Jan 27. pii: S0140-6736(16)32402.
    >> Share

  34. VICTORA CG, Castro MC, Franca GV, Schuler-Faccini L, et al
    Zika rash and increased risk of congenital brain abnormalities - Authors' reply.
    Lancet. 2017;389:152.
    >> Share

  35. VOUGA M, Musso D, Schaub B, Panchaud A, et al
    Zika virus: are we going too far?
    Lancet. 2017;389:151.
    >> Share

  36. GERARDIN P, Cao-Lormeau VM, Musso D, Despres P, et al
    Zika rash and increased risk of congenital brain abnormalities.
    Lancet. 2017;389:151-152.
    >> Share

    December 2016
  37. KODATI S, Palmore TN, Spellman FA, Cunningham D, et al
    Bilateral posterior uveitis associated with Zika virus infection.
    Lancet. 2016 Dec 7. pii: S0140-6736(16)32518.
    >> Share

    November 2016
  38. CARRUTH L, Roess AA, Mekonnen YT, Melaku SK, et al
    Zoonotic tuberculosis in Africa: challenges and ways forward.
    Lancet. 2016;388:2460-2461.
    >> Share

  39. GOMEZ-DANTES H, Fullman N, Lamadrid-Figueroa H, Cahuana-Hurtado L, et al
    Dissonant health transition in the states of Mexico, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
    Lancet. 2016;388:2386-2402.
    >> Share

  40. BERRY C, Achar J, du Cros P
    WHO recommendations for multidrug-resistant tuberculosis.
    Lancet. 2016;388:2234.
    >> Share

  41. SOTGIU G, Tiberi S, D'Ambrosio L, Centis R, et al
    WHO recommendations for multidrug-resistant tuberculosis - Authors' reply.
    Lancet. 2016;388:2234-2235.
    >> Share

  42. ZAK D, Scriba TJ, Hatherill M, Penn-Nicholson A, et al
    Predicting tuberculosis risk - Authors' reply.
    Lancet. 2016;388:2233-2234.
    >> Share

  43. KIK SV, Cobelens F, Moore D
    Predicting tuberculosis risk.
    Lancet. 2016;388:2233.
    >> Share

  44. GEORGE J
    Antibiotic-impregnated catheters for prevention of bloodstream infection.
    Lancet. 2016;388:2235.
    >> Share

  45. GILBERT RE, Mok Q, Millar M, Blundell M, et al
    Antibiotic-impregnated catheters for prevention of bloodstream infection - Authors' reply.
    Lancet. 2016;388:2235-2236.
    >> Share

    October 2016
  46. MEGRAUD F, Gisbert JP
    Towards effective empirical treatment for Helicobacter pylori eradication.
    Lancet. 2016 Oct 18. pii: S0140-6736(16)31657.
    >> Share

  47. LIOU JM, Fang YJ, Chen CC, Bair MJ, et al
    Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
    Lancet. 2016 Oct 18. pii: S0140-6736(16)31409.
    >> Share

  48. RADIN JM, Topol EJ, Andersen KG, Steinhubl SR, et al
    A laboratory in your pocket.
    Lancet. 2016;388:1875.
    >> Share

  49. NADDA JP, Singh PK
    New evidence of the tuberculosis burden in Asia demands national action.
    Lancet. 2016 Oct 14. pii: S0140-6736(16)31853.
    >> Share

  50. ALDRIDGE RW, Zenner D, White PJ, Williamson EJ, et al
    Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland.
    Lancet. 2016 Oct 10. pii: S0140-6736(16)31008.
    >> Share

  51. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    Lancet. 2016;388:1725-1774.
    >> Share

  52. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    Lancet. 2016;388:1459-1544.
    >> Share

  53. REINL J
    UN declaration on antimicrobial resistance lacks targets.
    Lancet. 2016;388:1365.
    >> Share

  54. TAM CC, Khan MS, Legido-Quigley H
    Where economics and epidemics collide: migrant workers and emerging infections.
    Lancet. 2016;388:1374-1376.
    >> Share

  55. CHEN S, Zhang H, Qu Y, Wu Y, et al
    Occupational challenges of physicians involved in tuberculosis control in China: a qualitative study.
    Lancet. 2016;388 Suppl 1:S88.
    >> Share

  56. GAO L, Bai L, Liu J, Lu W, et al
    Identification of populations at high risk of tuberculosis infection in rural China: a population-based, multicentre, prospective study.
    Lancet. 2016;388 Suppl 1:S16.
    >> Share

    September 2016
  57. LIU J, Platts-Mills JA, Juma J, Kabir F, et al
    Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study.
    Lancet. 2016;388:1291-301.
    >> Share

    Infective endocarditis.
    Lancet. 2016;388:1148.
    >> Share

  59. AKANMORI BD, Mukanga DO, Mihigo R, Ward M, et al
    New development of medicines for priority diseases in Africa.
    Lancet. 2016;388:1053-4.
    >> Share

    Zika's emerging threat for the Asia-Pacific region.
    Lancet. 2016;388:1026.
    >> Share

  61. CHO SY, Kang JM, Ha YE, Park GE, et al
    MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study.
    Lancet. 2016;388:994-1001.
    >> Share

    August 2016
  62. SLADE E, Dale A, Mahtani K
    Probiotics in very preterm infants: the PiPS trial.
    Lancet. 2016;388:656.
    >> Share

  63. DESHPANDE G, Rao S, Athalye-Jape G, Conway P, et al
    Probiotics in very preterm infants: the PiPS trial.
    Lancet. 2016;388:655.
    >> Share

  64. MCKINLAY CJ, Rebello C, Tarnow-Mordi W
    Probiotics in very preterm infants: the PiPS trial.
    Lancet. 2016;388:655.
    >> Share

  65. BURKI T
    Health crisis intensifying in Nigeria's Borno State.
    Lancet. 2016;388:645.
    >> Share

  66. METCALF CJ, Farrar J, Cutts FT, Basta NE, et al
    Use of serological surveys to generate key insights into the changing global landscape of infectious disease.
    Lancet. 2016;388:728-30.
    >> Share

  67. HUMBLE AG, Sample CB
    Morgagni's hernia in a hypoxaemic adult.
    Lancet. 2016;388:705.
    >> Share

    July 2016
    Legionnaires' disease: revisiting the puzzle of the century.
    Lancet. 2016;388:456-7.
    >> Share

  69. MILLAR M, Mok Q, Harron K, Gilbert R, et al
    Preventing bloodstream infection in children: What's the CATCH? - Authors' reply.
    Lancet. 2016;388:463.
    >> Share

  70. BOYD SE, Rawson TM, Moore LS, Holmes AH, et al
    Preventing bloodstream infection in children: What's the CATCH?
    Lancet. 2016;388:462-3.
    >> Share

  71. KIENY MP, Rottingen JA, Farrar J
    The need for global R&D coordination for infectious diseases with epidemic potential.
    Lancet. 2016;388:460-1.
    >> Share

    The Zika virus public health emergency: 6 months on.
    Lancet. 2016;388:449-50.
    >> Share

    Halting the Olympics-Zika virus bandwagon.
    Lancet. 2016;388:437.
    >> Share

  74. FEDER HM JR, Rigos L, Teti K
    Pott's disease in a Connecticut toddler.
    Lancet. 2016;388:504.
    >> Share

    Control of gonorrhoea and chlamydia in the UK.
    Lancet. 2016;388:342.
    >> Share

  76. CAHILL TJ, Prendergast BD
    Haemodialysis is a major risk factor for infective endocarditis - Authors' reply.
    Lancet. 2016;388:340.
    >> Share

  77. LABRIOLA L, Jadoul M
    Haemodialysis is a major risk factor for infective endocarditis.
    Lancet. 2016;388:339-40.
    >> Share

  78. MATONO T, Kato Y, Yotsu R, Ohmagari N, et al
    Duplicate publication.
    Lancet. 2016;388:238.
    >> Share

  79. LAXMINARAYAN R, Amabile-Cuevas CF, Cars O, Evans T, et al
    UN High-Level Meeting on antimicrobials--what do we need?
    Lancet. 2016;388:218-20.
    >> Share

  80. KAMARULZAMAN A, Reid SE, Schwitters A, Wiessing L, et al
    Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30769.
    >> Share

  81. ALTICE FL, Azbel L, Stone J, Brooks-Pollock E, et al
    The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30856.
    >> Share

  82. DOLAN K, Wirtz AL, Moazen B, Ndeffo-Mbah M, et al
    Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30466.
    >> Share

  83. RICH JD, Beckwith CG, Macmadu A, Marshall BD, et al
    Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30379.
    >> Share

  84. TELISINGHE L, Charalambous S, Topp SM, Herce ME, et al
    HIV and tuberculosis in prisons in sub-Saharan Africa.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30578.
    >> Share

    Tackling rheumatic heart disease in Indigenous Australians.
    Lancet. 2016;388:e1.
    >> Share

  86. LAZARUS C, Guichard M, Philippe JM, Paux T, et al
    The French experience of the threat posed by Zika virus.
    Lancet. 2016;388:9-11.
    >> Share

  87. DUA KS, Hogan WJ, Aadam AA, Gasparri M, et al
    In-vivo oesophageal regeneration in a human being by use of a non-biological scaffold and extracellular matrix.
    Lancet. 2016;388:55-61.
    >> Share

  88. BIRCHALL M, De Coppi P
    Novel approach to in-vivo oesophageal regeneration.
    Lancet. 2016;388:6-7.
    >> Share

    June 2016
  89. ROBERTS DJ, Frosch MP
    Zika and histopathology in first trimester infections.
    Lancet. 2016 Jun 29. pii: S0140-6736(16)30930.
    >> Share

  90. HEUKELBACH J, Werneck GL
    Surveillance of Zika virus infection and microcephaly in Brazil.
    Lancet. 2016 Jun 29. pii: S0140-6736(16)30931.
    >> Share

  91. FRANCA GV, Schuler-Faccini L, Oliveira WK, Henriques CM, et al
    Congenital Zika virus syndrome in Brazil: a case series of the first 1501 livebirths with complete investigation.
    Lancet. 2016 Jun 29. pii: S0140-6736(16)30902.
    >> Share

  92. MARTINES RB, Bhatnagar J, de Oliveira Ramos AM, Davi HP, et al
    Pathology of congenital Zika syndrome in Brazil: a case series.
    Lancet. 2016 Jun 29. pii: S0140-6736(16)30883.
    >> Share

  93. DONALD PR, Van Toorn R
    Use of corticosteroids in tuberculous meningitis.
    Lancet. 2016;387:2585-7.
    >> Share

  94. SOTGIU G, Tiberi S, D'Ambrosio L, Centis R, et al
    WHO recommendations on shorter treatment of multidrug-resistant tuberculosis.
    Lancet. 2016;387:2486-7.
    >> Share

  95. Dear Mr Ban Ki-moon.
    Lancet. 2016;387:2352.
    >> Share

  96. AMERATUNGA S, Denny S
    GBD 2013: a window into the world of young people.
    Lancet. 2016;387:2353-4.
    >> Share

  97. PATTON GC, Sawyer SM, Santelli JS, Ross DA, et al
    Our future: a Lancet commission on adolescent health and wellbeing.
    Lancet. 2016;387:2423-78.
    >> Share

  98. KLEINERT S, Horton R
    Adolescent health and wellbeing: a key to a sustainable future.
    Lancet. 2016;387:2355-6.
    >> Share

  99. MCGILL F, Heyderman RS, Panagiotou S, Tunkel AR, et al
    Acute bacterial meningitis in adults.
    Lancet. 2016 Jun 2. pii: S0140-6736(16)30654.
    >> Share

    May 2016
  100. CHAN M
    Yellow fever: the resurgence of a forgotten disease.
    Lancet. 2016;387:2165-6.
    >> Share

  101. DELFRAISSY JF, Yazdanpanah Y, Levy Y
    REACTing: the French response to infectious disease crises.
    Lancet. 2016;387:2183-5.
    >> Share

  102. WATTS G
    Thomas Herald Rea.
    Lancet. 2016;387:2086.
    >> Share

  103. MOKDAD AH, Forouzanfar MH, Daoud F, Mokdad AA, et al
    Global burden of diseases, injuries, and risk factors for young people's health during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
    Lancet. 2016 May 9. pii: S0140-6736(16)00648.
    >> Share

  104. SHAH A, Keir M, Ducas R, Crean AM, et al
    Uric acid bladder stones in congenital cyanotic heart disease.
    Lancet. 2016 May 5. pii: S0140-6736(16)00347.
    >> Share

    April 2016
  105. LEVY SD, Alladina JW, Hibbert KA, Harris RS, et al
    High-flow oxygen therapy and other inhaled therapies in intensive care units.
    Lancet. 2016;387:1867-78.
    >> Share

  106. GILBERT RE, Mok Q, Dwan K, Harron K, et al
    Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): a randomised controlled trial.
    Lancet. 2016;387:1732-42.
    >> Share

    Pragmatic trials in critically ill children are CATCHing on.
    Lancet. 2016;387:1697-8.
    >> Share

  108. NIELSEN KK, Bygbjerg IC
    Zika virus and hyperglycaemia in pregnancy.
    Lancet. 2016 Apr 18. pii: S0140-6736(16)30254.
    >> Share

    Recovery efforts in Flint slowly begin to take form.
    Lancet. 2016;387:1499-500.
    >> Share

    February 2016
  110. WILLISON HJ, Jacobs BC, van Doorn PA
    Guillain-Barre syndrome.
    Lancet. 2016 Feb 29. pii: S0140-6736(16)00339.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016